Skip to main content
. 2022 Jul 29;23(15):8373. doi: 10.3390/ijms23158373

Figure 7.

Figure 7

Exogenous ANP treatment in diet-induced obesity ameliorates not only systemic insulin resistance but also myocardial insulin resistance and protects against ischemia-reperfusion injury, which is associated with significant modifications of mitochondrial ultrastructure. CSCI, continuous subcutaneous infusion; IRI, ischemia-reperfusion injury; LD, lipid droplet; NAFLD, non-alcoholic fatty liver disease.